Pharmaceutical stocks exhibited continued strength, with Fengyuan Pharmaceutical reaching its daily trading limit, Hengrui Medicine surging over 7%, and other stocks like Hisun Pharmaceutical, Hendi Pharmaceutical, Asia-Pacific Pharmaceutical, and NIBIO closely trailing behind.